-
1
-
-
0032491164
-
Modes of myocardial cell injury and cell death in ischemic heart disease
-
Buja LM, Entman ML: Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation, 1998; 98: 1355-57
-
(1998)
Circulation
, vol.98
, pp. 1355-1357
-
-
Buja, L.M.1
Entman, M.L.2
-
2
-
-
0029024202
-
Myocardial reperfusion injury: Experimental evidence and clinical relevance
-
Hansen PR: Myocardial reperfusion injury: experimental evidence and clinical relevance. Eur Heart J, 1995; 16: 734-40
-
(1995)
Eur Heart J
, vol.16
, pp. 734-740
-
-
Hansen, P.R.1
-
3
-
-
0031055348
-
Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options
-
Maxwell SR, Lip GY: Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol, 1997; 58: 95-117
-
(1997)
Int J Cardiol
, vol.58
, pp. 95-117
-
-
Maxwell, S.R.1
Lip, G.Y.2
-
4
-
-
0036023614
-
Myocardial apoptosis and ischemic preconditioning
-
Zhao ZQ, Vinten-Johansen J: Myocardial apoptosis and ischemic preconditioning. Cardiovasc. Res, 2002; 55: 438-55
-
(2002)
Cardiovasc Res
, vol.55
, pp. 438-455
-
-
Zhao, Z.Q.1
Vinten-Johansen, J.2
-
5
-
-
0036156875
-
Losing heart: The role of apoptosis in heart disease - A novel therapeutic target?
-
Gill C, Mestril R, Samali A: Losing heart: the role of apoptosis in heart disease - a novel therapeutic target? FASEB J, 2002; 16: 135-46
-
(2002)
FASEB J
, vol.16
, pp. 135-146
-
-
Gill, C.1
Mestril, R.2
Samali, A.3
-
6
-
-
0025216421
-
Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode
-
Murry CE, Richard VJ, Reimer KA, Jennings RB: Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res, 1990; 66: 913-31
-
(1990)
Circ Res
, vol.66
, pp. 913-931
-
-
Murry, C.E.1
Richard, V.J.2
Reimer, K.A.3
Jennings, R.B.4
-
7
-
-
0025643349
-
Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical hemodynamic, and metabolic features
-
Deutsch E, Berger M, Kussmaul WG et al: Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical hemodynamic, and metabolic features. Circulation, 1990; 82: 2044-51
-
(1990)
Circulation
, vol.82
, pp. 2044-2051
-
-
Deutsch, E.1
Berger, M.2
Kussmaul, W.G.3
-
8
-
-
0037201970
-
Sphingosine-1-phosphate: Dual messenger functions
-
Payne S, Milstein A, Spiegel S: Sphingosine-1-phosphate: dual messenger functions. FEBS Lett, 2002; 531: 54-57
-
(2002)
FEBS Lett
, vol.531
, pp. 54-57
-
-
Payne, S.1
Milstein, A.2
Spiegel, S.3
-
9
-
-
1842455323
-
Point-Counterpoint of sphingosine 1-phosphate metabolism
-
Saba JD, Hla T: Point-Counterpoint of sphingosine 1-phosphate metabolism. Circ Res, 2004; 92: 724-34
-
(2004)
Circ Res
, vol.92
, pp. 724-734
-
-
Saba, J.D.1
Hla, T.2
-
10
-
-
0037162062
-
Lysophospholipids and the cardiovascular system
-
Karliner JS: Lysophospholipids and the cardiovascular system. Biochim Biophys Acta, 2002; 1582: 216-21
-
(2002)
Biochim Biophys Acta
, vol.1582
, pp. 216-221
-
-
Karliner, J.S.1
-
11
-
-
0034856123
-
The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes
-
Karliner JS, Honbo N, Summers K et al: The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol, 2001; 33: 1713-17
-
(2001)
J Mol Cell Cardiol
, vol.33
, pp. 1713-1717
-
-
Karliner, J.S.1
Honbo, N.2
Summers, K.3
-
12
-
-
4944246652
-
Sphingosine Kinase activation mediates ischemic preconditioning in murine hearts
-
Jin Z-Q, Goetzl EJ, Karliner JS: Sphingosine Kinase activation mediates ischemic preconditioning in murine hearts. Circulation, 2004; 110: 1980-89
-
(2004)
Circulation
, vol.110
, pp. 1980-1989
-
-
Jin, Z.-Q.1
Goetzl, E.J.2
Karliner, J.S.3
-
13
-
-
0036083489
-
Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCe knockout mouse hearts
-
Jin Z-Q, Zhou H-Z, Zhu P et al: Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCe knockout mouse hearts. Am J Physiol Heart Circ Physiol, 2002; 282: H1970-77
-
(2002)
Am J Physiol Heart Circ Physiol
, vol.282
-
-
Jin, Z.-Q.1
Zhou, H.-Z.2
Zhu, P.3
-
14
-
-
0036586721
-
Identification of a novel role for sphingolipid signaling in TNFa and ischemic preconditioning mediated cardioprotection
-
Lecour S, Smith RM, Woodward B et al: Identification of a novel role for sphingolipid signaling in TNFa and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol, 2002; 34: 509-18
-
(2002)
J Mol Cell Cardiol
, vol.34
, pp. 509-518
-
-
Lecour, S.1
Smith, R.M.2
Woodward, B.3
-
15
-
-
2142702839
-
Role of ceramide in ischemic preconditioning
-
Cui J, Engelman RM, Maulik N, Das DK: Role of ceramide in ischemic preconditioning. J Am Coll Surg, 2004; 198: 770-77
-
(2004)
J Am Coll Surg
, vol.198
, pp. 770-777
-
-
Cui, J.1
Engelman, R.M.2
Maulik, N.3
Das, D.K.4
-
16
-
-
7044245653
-
Influence of preischemic short-term triiodothyronine administration on hemodynamic function and metabolism of reperfused isolated rat heart
-
Kazmierczak P, Polak A, Mussur M: Influence of preischemic short-term triiodothyronine administration on hemodynamic function and metabolism of reperfused isolated rat heart. Med Sci Monit, 2004; 10(10): BR381-87
-
(2004)
Med Sci Monit
, vol.10
, Issue.10
-
-
Kazmierczak, P.1
Polak, A.2
Mussur, M.3
-
18
-
-
24644469502
-
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients
-
Schwab SR, Pereira JP, Matloubian M et al: Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science, 2005; 309: 1735-39
-
(2005)
Science
, vol.309
, pp. 1735-1739
-
-
Schwab, S.R.1
Pereira, J.P.2
Matloubian, M.3
-
19
-
-
0026656429
-
Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways
-
Buehrer BM, Bell RM: Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways. J Biol Chem, 1992; 267: 3154-59
-
(1992)
J Biol Chem
, vol.267
, pp. 3154-3159
-
-
Buehrer, B.M.1
Bell, R.M.2
-
20
-
-
0030054341
-
N-Dimethylsphingosine inhibition of sphingosine kinase and sphingosine-1-phosphate activity in human platelets
-
Yatomi Y, Ruan F, Mefidish T et al: N-Dimethylsphingosine inhibition of sphingosine kinase and sphingosine-1-phosphate activity in human platelets. Biochem, 1996; 35: 626-33
-
(1996)
Biochem
, vol.35
, pp. 626-633
-
-
Yatomi, Y.1
Ruan, F.2
Mefidish, T.3
-
21
-
-
0032508706
-
Molecular cloning and functional characterization of murine sphingosine kinase
-
Kohama T, Olivera A, Edsall L et al: Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem, 1998; 273: 12576-83
-
(1998)
J Biol Chem
, vol.273
, pp. 12576-12583
-
-
Kohama, T.1
Olivera, A.2
Edsall, L.3
-
22
-
-
0032524291
-
Purification and characterization of rat kidney sphingosine kinase
-
Olivera A, Kohama T, Tu Z et al: Purification and characterization of rat kidney sphingosine kinase. J Biol Chem, 1998; 273: 12576-83
-
(1998)
J Biol Chem
, vol.273
, pp. 12576-12583
-
-
Olivera, A.1
Kohama, T.2
Tu, Z.3
-
23
-
-
0034283195
-
Human sphingosine kinase: Purification, molecular cloning and characterization of the native and recombinant enzymes
-
Pitson SM, D'Andrea RJ, Vandeleur L et al: Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes. Biochem J,2000; 350: 429-41
-
(2000)
Biochem J
, vol.350
, pp. 429-441
-
-
Pitson, S.M.1
D'Andrea, R.J.2
Vandeleur, L.3
-
24
-
-
0142105397
-
Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation
-
Pitson SM, Moretti PAB, Zebol JR et al: Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J, 2003; 22: 5491-500
-
(2003)
EMBO J
, vol.22
, pp. 5491-5500
-
-
Pitson, S.M.1
Moretti, P.A.B.2
Zebol, J.R.3
|